This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

CleanPath Resources Corp Announces Worldwide Exclusive Stem Cell Enhancement Agreement With A Division Of Hemp, Inc.

PORT ST LUCIE, Fla., March 27, 2013 /PRNewswire/ -- CleanPath Resources Corp (OTC Pink: CLNP) ( announced today an exclusive agreement with the BioSwan™ division of Hemp, Inc. The agreement gives CleanPath exclusive rights to the new NutraLOAD™ stem enhancement product. NutraLOAD™ is an innovative new product shown to significantly increase the production of PluriCells™ in the body. 

PluriCells™ is the trademarked name given to the recently discovered and naturally occurring pluripotent stem cells found in everyone's body. These precious but scarce stem cells can differentiate into any tissue type in the body, just like the better known but highly controversial embryonic stem cells.

CleanPath believes that ingesting NutraLOAD™ on a daily basis can safely support an increase in PluriCells™ level in the body and thereby improving the healing process and promoting optimal cellular health without the risk and contention derived from embryonic stem cells.

NutraLOAD™ was developed by BioSwan, Inc. (, a Nevada based nutraceutical, stem cell, and medical device research company and subsidiary of Hemp, Inc. (OTC Pink: HEMP) (

The CEO of CleanPath, Ken Lewis, summed up his excitement about NutraLOAD™ by saying, "NutraLOAD™ represents the next chapter in cellular health, improved healing and breakthrough stem cell technology.  CleanPath is proud to lead the way in providing this game changing technology to its customers."

Ken Lewis1-561-309-9876

SOURCE CleanPath Resources Corp
Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 16,472.37 +200.36 1.23%
S&P 500 1,951.36 +27.54 1.43%
NASDAQ 4,707.7750 +80.6910 1.74%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs